Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of the risk of (a) all-cause and (b) cardiac death in the 12 weeks (i) before and (ii) after a covid-19 (A) vaccination and (B) infection.

As part of its ongoing rigorous safety monitoring of COVID-19 vaccines, the Medicines and Healthcare products Regulatory Agency (MHRA) closely reviews the Yellow Card reports it receives in the United Kingdom alongside safety data from its other sources from the UK and internationally, including mortality statistics. The MHRA also works closely with its UK public health partners to evaluate data on the safety and effectiveness of the COVID-19 vaccines. Following an assessment of the available data, the MHRA concluded that the evidence does not support an association between the COVID-19 vaccines and an increased risk of cardiac related death, or death from any cause. This conclusion has been supported by the independent Commission on Human Medicines’ COVID-19 Vaccine expert advisory group.